Alpha-1 Biologics Corporation
Developing diagnostics and therapeutics for restoring the immune system based on the human protein, alpha-1 proteinase inhibitor (alpha-1).
The discovery by Dr. Bristow that alpha-1 proteinase inhibitor (Alpha-1) stimulates the generation of new CD4 helper immune cells has led to the development of an urgently needed saliva-based diagnostic test for obtaining CD4 counts in HIV disease. Therapeutics are being developed based on alpha-1. A second clinical trial is underway to treat HIV patients using alpha-1 to elevate CD4 counts. As a bonus, alpha-1 also lowers LDL and elevates HDL.